All Programs

Use the tool below to view all available Series

NEW EPISODE
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits
NEW EPISODE
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
0.50 program credits
- Erica L. Mayer, MD, MPH
0.50 program credits
MinuteCE®
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO; Erica L. Mayer, MD, MPH
0.50 credits 3 episodes
- Aditya Bardia, MD, MPH, FASCO
- Erica L. Mayer, MD, MPH
0.50 credits 3 episodes
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CE
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
Jennifer R. Brown, MD, PhD; William Mencia, MD, FACEHP
0.25 credits
- Jennifer R. Brown, MD, PhD
- William Mencia, MD, FACEHP
0.25 credits
Personalizing First-Line Therapy for CLL
Personalizing First-Line Therapy for CLL
CME/CE
Personalizing First-Line Therapy for CLL
William Wierda, MD, PhD; Matthew S. Davids, MD, MMSc
0.25 credits
- William Wierda, MD, PhD
- Matthew S. Davids, MD, MMSc
0.25 credits
Treat-to-Target: Are We There Yet? 
Treat-to-Target: Are We There Yet? 
MinuteCE®
Treat-to-Target: Are We There Yet? 
Kimberly D. Orleck, PA-C; Jennifer Geremia, PA-C
1.00 program credit
- Kimberly D. Orleck, PA-C
- Jennifer Geremia, PA-C
1.00 program credit
IBD Immunopathogenesis: Do You Know What You're Blocking?
IBD Immunopathogenesis: Do You Know What You're Blocking?
MinuteCE®
IBD Immunopathogenesis: Do You Know What You're Blocking?
Kimberly D. Orleck, PA-C; Brooke Hodnick, PA-C, MPAS
1.00 program credit
- Kimberly D. Orleck, PA-C
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  
MinuteCE®
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  
Kimberly D. Orleck, PA-C; Jennifer Geremia, PA-C
1.00 program credit
- Kimberly D. Orleck, PA-C
- Jennifer Geremia, PA-C
1.00 program credit
Severity Assessment: Can You Pin the Stage on the Patient?
Severity Assessment: Can You Pin the Stage on the Patient?
MinuteCE®
Severity Assessment: Can You Pin the Stage on the Patient?
Jennifer Geremia, PA-C; Brooke Hodnick, PA-C, MPAS
1.00 program credit
- Jennifer Geremia, PA-C
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
Case Review: Can You Crack This IBD Case? 
Case Review: Can You Crack This IBD Case? 
MinuteCE®
Case Review: Can You Crack This IBD Case? 
David Rubin, MD; Kimberly D. Orleck, PA-C
1.00 program credit
- David Rubin, MD
- Kimberly D. Orleck, PA-C
1.00 program credit
Remission: Can You Prove It? 
Remission: Can You Prove It? 
MinuteCE®
Remission: Can You Prove It? 
David Rubin, MD; Kimberly D. Orleck, PA-C
1.00 program credit
- David Rubin, MD
- Kimberly D. Orleck, PA-C
1.00 program credit
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
MinuteCE®
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
Nancy S. Reau, MD
1.00 program credit
- Nancy S. Reau, MD
1.00 program credit
The Slippery Slope of Overt Hepatic Encephalopathy
The Slippery Slope of Overt Hepatic Encephalopathy
MinuteCE®
The Slippery Slope of Overt Hepatic Encephalopathy
Arun B. Jesudian, MD; Nancy S. Reau, MD
1.00 program credit
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 program credit
MinuteCE®
Clearing the Brain Fog: Innovations in the Treatment and Management of Hepatic Encephalopathy
Arun B. Jesudian, MD; Nancy S. Reau, MD
1.00 credit 9 episodes
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 credit 9 episodes
Precision Treatment Pathways for MDD and Comorbid Insomnia
Precision Treatment Pathways for MDD and Comorbid Insomnia
CME/CE
Precision Treatment Pathways for MDD and Comorbid Insomnia
Michael E. Thase, MD
0.25 credits
- Michael E. Thase, MD
0.25 credits
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
MinuteCE®
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
James M. Cleary, MD, PhD
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits

All Programs

Popular

Title